Benefits of Adjuvant Chemotherapy for Bladder Cancer

JAMA Oncol. 2015 Sep;1(6):727-8. doi: 10.1001/jamaoncol.2015.1210.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Chemotherapy, Adjuvant
  • Evidence-Based Medicine
  • Humans
  • Neoadjuvant Therapy* / adverse effects
  • Neoadjuvant Therapy* / mortality
  • Practice Guidelines as Topic
  • Risk Assessment
  • Risk Factors
  • Standard of Care
  • Treatment Outcome
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / mortality
  • Urinary Bladder Neoplasms / pathology

Substances

  • Antineoplastic Agents